Question

Difficulty: HardPulmonary and Critical Care

A 54-year-old woman is evaluated in the intensive care unit for worsening respiratory distress. She was admitted 48 hours ago for a severe right lower lobe community-acquired pneumonia and was started on intravenous ceftriaxone and azithromycin. Blood and sputum cultures drawn on admission are now growing *Streptococcus pneumoniae* susceptible to penicillin.

Current vital signs are:
Temperature: 38.9°C (102.0°F)
Pulse: 124/min
Blood pressure: 82/50 mmHg
Respirations: 32/min
SpO2: 87% on a high-flow nasal cannula (FiO2 60%)

Over the past 4 hours, she has received 3 L of intravenous normal saline without improvement in her blood pressure. Physical examination reveals cool, mottled extremities. Jugular venous pressure is 5 cm H2O. Pulmonary auscultation reveals diffuse bilateral crackles, a change from the isolated right-sided crackles noted on admission. A bedside chest radiograph demonstrates new, diffuse bilateral alveolar opacities in addition to the right lower lobe consolidation.

Laboratory results:
Leukocytes: 18,500/mm³
Serum sodium: 138 mEq/L
Serum potassium: 4.8 mEq/L
Serum chloride: 101 mEq/L
Serum bicarbonate: 13 mEq/L
Blood urea nitrogen: 34 mg/dL
Serum creatinine: 2.2 mg/dL
Serum lactate: 6.5 mmol/L

Arterial blood gas (on HFNC 60%):
pH: 7.20
PaCO2: 35 mmHg
PaO2: 55 mmHg

Which of the following statements regarding this patient's condition and management are correct? (Select all that apply)

  1. The patient has a mixed metabolic acidosis and concurrent respiratory acidosisAnswer
  2. Initiation of a continuous intravenous norepinephrine infusion is indicatedAnswer
  3. C
    Intravenous furosemide should be administered to treat the new bilateral alveolar opacities
  4. D
    Antibiotic therapy should be broadened to include intravenous vancomycin
  5. E
    The arterial blood gas values indicate appropriate physiological respiratory compensation

Answer

The patient has a mixed metabolic acidosis with concurrent respiratory acidosis, and requires initiation of a continuous intravenous norepinephrine infusion.
The patient is experiencing fluid-refractory septic shock complicated by Acute Respiratory Distress Syndrome (ARDS) and impending respiratory failure. Despite 3 L of crystalloids, she remains hypotensive, mandating the initiation of a vasopressor (norepinephrine is first-line). Additionally, she has a severe high anion gap metabolic acidosis (lactate 6.5 mmol/L, HCO3 13 mEq/L). Winter's formula calculation (PaCO2=(1.5×13)+8±2PaCO_2 = (1.5 \times 13) + 8 \pm 2) predicts an expected PaCO2 of 25.5 to 29.5 mmHg. Her actual PaCO2 of 35 mmHg is higher than expected, indicating inadequate respiratory compensation and a concurrent respiratory acidosis due to muscle fatigue and ARDS.

Step-by-Step Solution

1
Assess the patient's hemodynamic status and response to initial resuscitation.
The patient remains severely hypotensive (BP 82/50 mmHg) despite receiving 3 L of intravenous fluids, indicating fluid-refractory septic shock.
Identifying fluid-refractory shock determines the need for immediate vasopressor support, with norepinephrine being the first-line agent.
2
Analyze the arterial blood gas to determine the primary acid-base disorder.
The pH is 7.20 (acidemia) and HCO3 is 13 mEq/L, confirming a primary metabolic acidosis (driven by elevated lactate).
Establishing the primary disorder is required before calculating the expected physiological compensatory response.
3
Calculate the expected respiratory compensation using Winter's formula.
PaCO2=(1.5×13)+8±2=27.5±2 mmHgPaCO_2 = (1.5 \times 13) + 8 \pm 2 = 27.5 \pm 2\text{ mmHg}. The measured PaCO2 (35 mmHg) is higher than expected.
Comparing measured to expected PaCO2 reveals a concurrent respiratory acidosis, indicating the patient's work of breathing is failing and complete respiratory collapse is imminent.
4
Evaluate the clinical and radiographic pulmonary findings in the context of sepsis.
New diffuse bilateral alveolar opacities and severe hypoxemia in a septic patient signify Acute Respiratory Distress Syndrome (ARDS), a form of noncardiogenic pulmonary edema.
Distinguishing ARDS from cardiogenic edema ensures inappropriate treatments like diuretics are avoided in a hypoperfused, hypovolemic state.

Key Concept

In patients with severe metabolic acidosis, failure to achieve the target PaCO2 calculated by Winter's formula indicates a concurrent respiratory acidosis and impending respiratory failure. Fluid-refractory septic shock requires prompt initiation of norepinephrine.
Rate this question